PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574957
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574957
Antimicrobial Resistance Surveillance Market size was valued at USD 5,904.09 million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.
Antimicrobial resistance surveillance checks how well antibiotics and other antimicrobial drugs work against bacteria, viruses, and fungi. It helps to identify patterns of resistance, which guides healthcare providers in choosing the right treatments. This information also supports public health policies and strategies to fight the problem. By collecting data from hospitals, labs, and communities, health organizations can better understand the extent of resistance and work to lessen its impact on public health. This ongoing effort is crucial for making sure effective treatments are available for infections.
Antimicrobial Resistance Surveillance Market- Market Dynamics
Rising healthcare-associated infections necessitate enhanced surveillance and control measures.
The rising incidence of antimicrobial resistance (AMR) is a significant driver for the AMR surveillance market, as it poses a threat to global health. The increasing prevalence of resistant infections has led healthcare authorities to prioritize monitoring and research initiatives to combat this crisis.
According to the Centers for Disease Control and Prevention (CDC), nearly 3 million antibiotic-resistant infections occur in the U.S. each year, highlighting the urgent need for enhanced surveillance systems. As governments and educational institutions invest in AMR surveillance, the demand for innovative technologies and Technology continues to grow, making it a critical area for investment and research.
Antimicrobial Resistance Surveillance Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)
Based on Technology segmentation, PCR (Polymerase Chain Reaction) was predicted to show maximum market share in the year 2023
Based on Application segmentation, Public Health Surveillance was the leading type in 2023
Based on End User segmentation, Hospitals was the leading type in 2023
based on Region, North America was the leading revenue generator in 2023
The Global Antimicrobial Resistance Surveillance Market is segmented based on Technology, Application, End-User, and Region.
The market is divided into six categories based on Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (next-generation sequencing), Mass Spectrometry, Rapid & Point of Care, and Others. PCR (Polymerase Chain Reaction) is the most significant segment in the Antimicrobial Resistance Surveillance Market. PCR is popular because it allows for quick and accurate detection of resistant bacteria.
This method works by amplifying specific DNA sequences, making it easier to identify pathogens and their resistance genes. Its speed and precision make it crucial for timely responses in healthcare settings, helping to control and manage infections effectively. As antibiotic resistance becomes a growing concern, PCR's role in surveillance continues to expand.
The market is divided into Three categories based on Application: Public health surveillance, Laboratory surveillance, Clinical diagnostics, and Others. Public Health Surveillance is the most significant segment of the Antimicrobial Resistance (AMR) Surveillance Market. This method involves collecting and analysing data on AMR to help health authorities monitor trends and outbreaks.
Public health surveillance is crucial for making informed policy decisions, guiding treatment plans, and effectively allocating resources. By identifying specific resistant strains in different populations, this approach enables targeted measures to mitigate the spread of resistance. Its role in improving patient outcomes and strengthening public health strategies makes it a key player in the AMR field, influencing future efforts in antimicrobial management and infection control.
Antimicrobial Resistance Surveillance Market- Geographical Insights
The Antimicrobial Resistance (AMR) Surveillance Market in North America is growing due to rising concerns about infections that do not respond to standard treatments. This region has well-established healthcare systems and regulatory bodies that support monitoring and research on AMR. Increased funding for healthcare initiatives and the development of advanced technologies are driving market growth.
Public awareness campaigns highlight the importance of tracking antibiotic resistance, further boosting the demand for surveillance Technology. Overall, North America is working to improve ways to fight antibiotic resistance and keep people healthy.
The Antimicrobial Resistance (AMR) Surveillance market is growing rapidly because drug-resistant infections are becoming a bigger problem around the world. Companies like Thermo Fisher Scientific, bioMerieux, BD (Becton, Dickinson, and Company), and Cepheid are leading the way by creating advanced tools and systems to detect and track these resistant bacteria. They focus on testing methods, automated systems, and global networks to monitor resistance trends.
Collaborations between governments, healthcare organizations, and these companies are helping the market grow. Improvements in data analysis and machine learning are making it easier to predict AMR patterns, making this market very important for public health.
In February 2024, Visby Medical launched a rapid gonorrhea test that includes antimicrobial resistance profiling, addressing the growing challenge of resistant infections. This innovation aims to improve treatment effectiveness and public health management of gonorrhea
In November 2023, Ginkgo Bioworks and XWELL announced an expansion of their CDC traveler-based genomic surveillance program. This initiative aims to enhance public health efforts by testing for more than 30 known pathogens in travelers, thereby improving the ability to monitor and prevent potential outbreaks.